Ipamorelin 5 mg, glass vial, crimp seal, flip-top cap, California Standard Peptides label

Hormones

Ipamorelin

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue developed at Novo Nordisk and described in 1998 as the first selective agent of its class.

5 mgCS-IPA-5$40.00
10 mgCS-IPA-10$60.00
Choose a size and add to cart →
Container
Glass vial, crimp seal, flip-top cap
Storage
-20 °C, desiccated
Paperwork
Lot certificate (HPLC + mass spec) shown before you pay

Lot certificates

You’ll see American Peptides on the lab’s copy. They’re our supplier.

  • 5 mg, lot IPA5-0803: 99.78% purity (RP-HPLC), 5.17 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7600
  • 10 mg, lot IPA10-0803: 99.78% purity (RP-HPLC), 10.15 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7624

Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.

What researchers study it for

  • Selective growth hormone release
  • Pituitary hormone selectivity in animal models
  • Human pharmacokinetics and GH response
  • Postoperative ileus (phase 2 trial)

How it is thought to work

Ipamorelin acts on the ghrelin receptor (GHS-R1a), stimulating growth hormone release from the pituitary. In swine it did not raise ACTH or cortisol, unlike GHRP-2 and GHRP-6. A human study in healthy volunteers observed a single, short-lived GH release episode.

Where the research stands

Phase 2 tested; not approved. A phase 2 placebo-controlled trial in bowel-resection patients (NCT00672074, 117 enrolled) found it well tolerated but showed no significant difference from placebo on recovery endpoints.

Sources

  1. Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH (1998). Ipamorelin, the first selective growth hormone secretagogue.. Eur J Endocrinol.
  2. Gobburu JV, Agersø H, Jusko WJ, Ynddal L (1999). Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.. Pharm Res.
  3. Beck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group (2014). Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.. Int J Colorectal Dis.
  4. Helsinn Therapeutics (U.S.), Inc (sponsor) (). A Phase II, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Ipamorelin Compared to Placebo for the Management of Post-Operative Ileus in Patients. ClinicalTrials.gov.

Read more

For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.

California Standard Peptides

Your cart

0 items · free shipping over $200.00

Your cart is empty.

Buy 2 of a vial and save 10%, 3 and save 15%. Research sets are 15% off, and shipping is free over $200.00.

First order

20% off your first order.

Join the list for first word on new lots, restocks and member pricing. Your code arrives by email and applies by itself at checkout.

One code per email, for your first order. By signing up you agree to get emails from us. Unsubscribe anytime.

For laboratory research use only. 21+.